GlassScriptPhysician profile
Jean B Gue
NPI 1831434257
$11,960.38
in general payments reported to CMS, 2019-2025
29 companies · $5,707 in 2025
The $5,707 reported for 2025 was more than what 84% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $575 · 2020: $937 · 2021: $1,428 · 2022: $585 · 2023: $1,777 · 2024: $952 · 2025: $5,707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,702 · Food and Beverage: $3,734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,702.05 |
| Food and Beverage | $3,733.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,783.16 | 2021-2025 | Pascal, Evoque |
| Abbott Laboratories | $3,280.75 | 2021-2025 | Triclip, Acculink, Navitor |
| Medtronic, INC. | $913.82 | 2021-2024 | Symplicity G3, Linq II |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $559.63 | 2019-2025 | Lifevest |
| Abiomed | $432.31 | 2020-2025 | Impella |
| Inari Medical, INC. | $366.49 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $331.40 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $330.26 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $291.53 | 2020-2025 | |
| Cardiovascular Systems INC. | $194.94 | 2020-2022 | |
| Astellas Pharma US INC | $185.17 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $161.73 | 2020-2025 | Farxiga |
| Philips North America LLC | $149.56 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $128.67 | 2023-2025 | Eliquis, Camzyos |
| Penumbra, INC. | $124.86 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $120.11 | 2020 | |
| Amgen INC. | $111.72 | 2023-2025 | Repatha |
| Janssen Pharmaceuticals, INC | $111.48 | 2019-2024 | Xarelto |
| Preventice Services, LLC | $110.64 | 2020 | |
| Pfizer INC. | $85.42 | 2019-2024 | |
| Medtronic Vascular, INC. | $32.64 | 2019-2020 | |
| Atricure, INC. | $32.49 | 2023 | |
| Inspire Medical Systems, INC. | $23.06 | 2025 | Inspire |
| Medicomp INC | $18.25 | 2025 | Telepatch Cardiac Monitor |
| Stryker Corporation | $17.42 | 2025 | Flowtriever |
| W. L. Gore & Associates, INC. | $17.29 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.09 | 2024 | Jardiance |
| Kiniksa Pharmaceuticals, LTD. | $14.31 | 2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $14.18 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jean Gue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.